1. Home
  2. AZN vs PEP Comparison

AZN vs PEP Comparison

Compare AZN & PEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZN
  • PEP
  • Stock Information
  • Founded
  • AZN 1992
  • PEP 1898
  • Country
  • AZN United Kingdom
  • PEP United States
  • Employees
  • AZN N/A
  • PEP N/A
  • Industry
  • AZN Biotechnology: Pharmaceutical Preparations
  • PEP Beverages (Production/Distribution)
  • Sector
  • AZN Health Care
  • PEP Consumer Staples
  • Exchange
  • AZN Nasdaq
  • PEP Nasdaq
  • Market Cap
  • AZN 252.9B
  • PEP 205.9B
  • IPO Year
  • AZN 1993
  • PEP N/A
  • Fundamental
  • Price
  • AZN $77.92
  • PEP $140.78
  • Analyst Decision
  • AZN Strong Buy
  • PEP Buy
  • Analyst Count
  • AZN 1
  • PEP 14
  • Target Price
  • AZN N/A
  • PEP $156.85
  • AVG Volume (30 Days)
  • AZN 3.3M
  • PEP 8.4M
  • Earning Date
  • AZN 11-11-2025
  • PEP 10-09-2025
  • Dividend Yield
  • AZN 1.97%
  • PEP 4.04%
  • EPS Growth
  • AZN 28.86
  • PEP N/A
  • EPS
  • AZN 5.31
  • PEP 5.49
  • Revenue
  • AZN $56,501,000,000.00
  • PEP $91,748,000,000.00
  • Revenue This Year
  • AZN $10.57
  • PEP $2.38
  • Revenue Next Year
  • AZN $6.25
  • PEP $3.12
  • P/E Ratio
  • AZN $29.02
  • PEP $25.62
  • Revenue Growth
  • AZN 15.00
  • PEP N/A
  • 52 Week Low
  • AZN $61.24
  • PEP $127.60
  • 52 Week High
  • AZN $82.41
  • PEP $179.43
  • Technical
  • Relative Strength Index (RSI)
  • AZN 44.43
  • PEP 39.97
  • Support Level
  • AZN $77.36
  • PEP $140.35
  • Resistance Level
  • AZN $81.31
  • PEP $144.75
  • Average True Range (ATR)
  • AZN 0.94
  • PEP 2.78
  • MACD
  • AZN -0.62
  • PEP -1.03
  • Stochastic Oscillator
  • AZN 11.09
  • PEP 2.44

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

About PEP PepsiCo Inc.

PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US, but uses bottlers overseas for beverages. International markets made up 40% of both total sales and operating profits in 2024.

Share on Social Networks: